-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 16, the State Food and Drug Administration issued an announcement stating that in accordance with Article 83 of the Drug Administration Law of the People’s Republic of China and other relevant regulations, the State Food and Drug Administration organized the inspection of pediatric phenol Amin Granules, Aminophena Tablets, and Compound Amino Acids.
Post-marketing evaluations were carried out on 8 varieties of Bilin theophylline tablets, amlinfenol capsules, aminocamin tablets, bufenac cream, children's compound aspirin tablets, and amphioxacin tablets
.
Post-marketing evaluations were carried out on 8 varieties of Bilin theophylline tablets, amlinfenol capsules, aminocamin tablets, bufenac cream, children's compound aspirin tablets, and amphioxacin tablets
.
After evaluation, the State Drug Administration has decided to stop the production, sales and use of the above-mentioned eight varieties in China and cancel the drug registration certificate from now on
.
Products that have been on the market shall be recalled by the drug marketing license holder, and the recalled products shall be supervised and destroyed by the local provincial drug regulatory authority or other measures such as harmless treatment shall be taken in accordance with the law
.
.
Products that have been on the market shall be recalled by the drug marketing license holder, and the recalled products shall be supervised and destroyed by the local provincial drug regulatory authority or other measures such as harmless treatment shall be taken in accordance with the law
.
Appendix:
Information table of8 varieties such as pediatric phenol aminoglycerin granules
On November 16, the State Food and Drug Administration issued an announcement stating that in accordance with Article 83 of the Drug Administration Law of the People’s Republic of China and other relevant regulations, the State Food and Drug Administration organized the inspection of pediatric phenol Amin Granules, Aminophena Tablets, and Compound Amino Acids.
Post-marketing evaluations were carried out on 8 varieties of Bilin theophylline tablets, amlinfenol capsules, aminocamin tablets, bufenac cream, children's compound aspirin tablets, and amphioxacin tablets
.
Post-marketing evaluations were carried out on 8 varieties of Bilin theophylline tablets, amlinfenol capsules, aminocamin tablets, bufenac cream, children's compound aspirin tablets, and amphioxacin tablets
.
After evaluation, the State Drug Administration has decided to stop the production, sales and use of the above-mentioned eight varieties in China and cancel the drug registration certificate from now on
.
Products that have been on the market shall be recalled by the drug marketing license holder, and the recalled products shall be supervised and destroyed by the local provincial drug regulatory authority or other measures such as harmless treatment shall be taken in accordance with the law
.
.
Products that have been on the market shall be recalled by the drug marketing license holder, and the recalled products shall be supervised and destroyed by the local provincial drug regulatory authority or other measures such as harmless treatment shall be taken in accordance with the law
.
Appendix:
Information table of 8 varieties such as pediatric phenol aminoglycerin granules
On November 16, the State Food and Drug Administration issued an announcement stating that in accordance with Article 83 of the Drug Administration Law of the People’s Republic of China and other relevant regulations, the State Food and Drug Administration organized the inspection of pediatric phenol Amin Granules, Aminophena Tablets, and Compound Amino Acids.
Post-marketing evaluations were carried out on 8 varieties of Bilin theophylline tablets, amlinfenol capsules, aminocamin tablets, bufenac cream, children's compound aspirin tablets, and amphioxacin tablets
.
Post-marketing evaluations were carried out on 8 varieties of Bilin theophylline tablets, amlinfenol capsules, aminocamin tablets, bufenac cream, children's compound aspirin tablets, and amphioxacin tablets
.
After evaluation, the State Drug Administration has decided to stop the production, sales and use of the above-mentioned eight varieties in China and cancel the drug registration certificate from now on
.
Products that have been on the market shall be recalled by the drug marketing license holder, and the recalled products shall be supervised and destroyed by the local provincial drug regulatory authority or other measures such as harmless treatment shall be taken in accordance with the law
.
Drugs Drugs Drugs Drug Registration Drug Registration Drug Registration.
Products that have been on the market shall be recalled by the drug marketing license holder, and the recalled products shall be supervised and destroyed by the local provincial drug regulatory authority or other measures such as harmless treatment shall be taken in accordance with the law
.
Appendix:
Appendix:Information table of 8 varieties such as pediatric phenol aminoglycerin granules
Information table of 8 varieties such as pediatric phenol aminoglycerin granules 
